Drug firm Zydus Cadila has received approval from the US health regulator to market fluconazole tablets used for the treatment of fungal infections. The company also received approval for Clobetasol Propionate spray used in the treatment of various skin ... Business Standard, 2 days ago
Drug firm Cadila Healthcare today said it has settled all outstanding patent litigation related to Qudexy XR (topiramate) extended-release capsules with US-based Upsher-Smith Laboratories, Inc. The company and its subsidiary, Zydus Pharmaceuticals (USA) Inc, ...Business Standard, 1 month ago
Posted by Equitymaster Global markets ended the week on a dull note with most of the markets ending flat or in the negative territory. Brazil's and China's indices were the only ones which ended the week on a positive note, with gains of 0.5% and 0.3% ...Equitymaster.com, 1 month ago
on your WebpageAdd Widget >Get your members hooked!